Search

Your search keyword '"Le Cesne, A."' showing total 1,232 results

Search Constraints

Start Over You searched for: Author "Le Cesne, A." Remove constraint Author: "Le Cesne, A." Search Limiters Full Text Remove constraint Search Limiters: Full Text
1,232 results on '"Le Cesne, A."'

Search Results

1. Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial

2. Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study

3. Why cave planthoppers study matters: are Cixiidae a subtroglophile lineage? (Hemiptera, Fulgoromorpha)

4. Malagasy spittlebugs (Hemiptera: Cercopidae), a taxonomic review of genera from Madagascar

5. Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial

6. Investigating the prognostic impact of NY-ESO-1 expression and HLA subtypes in metastatic synovial sarcoma

7. Single-cell multiomics profiling reveals heterogeneous transcriptional programs and microenvironment in DSRCTs

9. Improved nationwide survival of sarcoma patients with a network of reference centers

10. A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse

11. Handling missing covariates in observational studies: an illustration with the assessment of prognostic factors of survival outcomes in soft-tissue or visceral sarcomas in irradiated fields (SIF)

12. Leiomyosarcoma and liposarcoma in young patients: The national netsarc+ network experience

13. Leiomyosarcoma and liposarcoma in young patients: The national netsarc+ network experience

14. Single‐agent gemcitabine in patients with advanced, pre‐treated angiosarcoma: A multicenter, retrospective study

15. Overview of the role of liquid biopsy in cancer management

20. Management and outcomes of adolescent and young adult sarcoma patients: results from the French nationwide database NETSARC

23. Desmoid type fibromatosis in pediatric and young adults from French databases: Clinical characteristics and initial outcome according to age

24. CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response

26. VP3-2024: A randomized study of 6 vs 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse

27. Coframalaxius bletteryi gen. et sp. nov. from subterranean habitat in Southern France (Hemiptera, Fulgoromorpha, Cixiidae, Oecleini)

30. Patterns of care and outcomes of 417 patients with METAstatic SYNovial sarcoma (METASYN): real-life data from the French Sarcoma Group (FSG)

31. Desmoid type fibromatosis in pediatric and young adults from French databases: Clinical characteristics and initial outcome according to age

32. Medium levels of transcription and replication related chromosomal instability are associated with poor clinical outcome

33. 62P Updated overall survival and safety with ripretinib vs sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib and harboring KIT exon 11 + 17/18 mutations: ctDNA analysis from INTRIGUE

34. 52O Resistance to imatinib induced by treatment interruption in advanced GIST: Long-term outcome of the randomized BFR14 study

35. 55O IMADGIST: A randomized study of 6 vs 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse

37. A randomized phase III trial comparing trabectedin to best supportive care in patients with pre-treated soft tissue sarcoma: T-SAR, a French Sarcoma Group trial

38. A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery

40. Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts

41. LAG-3 Inhibitors: Novel Immune Checkpoint Inhibitors Changing the Landscape of Immunotherapy

42. Prospective evaluation of intensity-modulated radiotherapy toxicity in extremity soft tissue sarcomas patients: A role for irradiated healthy soft tissue volume?

43. Determinants of the access to remote specialised services provided by national sarcoma reference centres

44. Male terminalia of Cercopidae (Hemiptera, Cicadomorpha): towards a consensus terminology

45. Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)☆

47. Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up

48. Cercopidae spittle-bugs (Hemiptera, Cicadomorpha) of Madagascar: a new species of Bourgoinrana and revision of the Locris species

49. Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network

50. The Evolving Role of Bispecific Antibodies in Diffuse Large B-Cell Lymphoma.

Catalog

Books, media, physical & digital resources